Crown Laboratories Acquires Aesthetics Eclipse’s Aesthetics Portfolio
Skincare company Crown Laboratories has finalized an agreement to acquire the global, aesthetics-focused assets of medical technology company Eclipse.
Skincare company Crown Laboratories has finalized an agreement to acquire the global, aesthetics-focused assets of medical technology company Eclipse.
The professional-exclusive serum and cream use epidermal growth factor and amino acids to support skin barrier repair, with small clinical studies reporting improvements in redness, hydration, and recovery following aesthetic procedures.